1,2-dimyristoylphosphatidylethanolamine and dapi

1,2-dimyristoylphosphatidylethanolamine has been researched along with dapi in 1 studies

Compound Research Comparison

Studies (1,2-dimyristoylphosphatidylethanolamine)	Trials (1,2-dimyristoylphosphatidylethanolamine)	Recent Studies (post-2010) (1,2-dimyristoylphosphatidylethanolamine)	Studies (dapi)	Trials (dapi)	Recent Studies (post-2010) (dapi)
216	0	59	2,424	6	566

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fayad, ZA; Fisher, EA; Frias, JC; Williams, KJ	1

Other Studies

1 other study(ies) available for 1,2-dimyristoylphosphatidylethanolamine and dapi

Article	Year
Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. Journal of the American Chemical Society, 2004, Dec-22, Volume: 126, Issue:50 Topics: Arteriosclerosis; Contrast Media; Fluorescent Dyes; Gadolinium DTPA; Humans; Indoles; Lipoproteins, HDL; Magnetic Resonance Imaging; Microscopy, Confocal; Microscopy, Fluorescence; Nanostructures; Phosphatidylethanolamines; Recombinant Proteins	2004

Article

Year

Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques.

Journal of the American Chemical Society, 2004, Dec-22, Volume: 126, Issue:50

Topics: Arteriosclerosis; Contrast Media; Fluorescent Dyes; Gadolinium DTPA; Humans; Indoles; Lipoproteins, HDL; Magnetic Resonance Imaging; Microscopy, Confocal; Microscopy, Fluorescence; Nanostructures; Phosphatidylethanolamines; Recombinant Proteins

2004